Q2 2026 Earnings Call July 29, 2026 5:00 PM EDTCompany ParticipantsAl Galgano - Investor Relations ContactVincent Kelly ...
You will be redirected to our submission process. The field of gene and cell therapy has entered a transformative phase, with viral and non‑viral delivery systems enabling precise correction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results